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Abstract
Background: Repetitive functional task practise (RFTP) is a promising treatment to improve upper limb recovery
following stroke. We report the findings of a study to determine the feasibility of a multi-centre randomised
controlled trial to evaluate this intervention.
Methods: A pilot randomised controlled trial recruited patients with new reduced upper limb function within
14 days of acute stroke from three stroke units. Participants were randomised to receive a four week upper limb
RFTP therapy programme consisting of goal setting, independent activity practise, and twice weekly therapy
reviews in addition to usual post stroke rehabilitation, or usual post stroke rehabilitation. The recruitment rate;
adherence to the RFTP therapy programme; usual post stroke rehabilitation received; attrition rate; data quality;
success of outcome assessor blinding; adverse events; and the views of study participants and therapists about
the intervention were recorded.
Results: Fifty five eligible patients were identified, 4-6 % of patients screened at each site. Twenty four patients
participated in the pilot study. Two study sites met the recruitment target of 1–2 participants per month. The
median number of face to face therapy sessions received was 6 [IQR 3–8]. The median number of daily repetitions
of activities recorded was 80 [IQR 39–80]. Data about usual post stroke rehabilitation were available for 18/24 (75 %).
Outcome data were available for 22/24 (92 %) at one month and 20/24 (83 %) at three months. Outcome assessors
were unblinded to participant group allocation for 11/22 (50 %) at one month and 6/20 (30 %) at three months.
Four adverse events were considered serious as they resulted in hospitalisation. None were related to study treatment.
Feedback from patients and therapists about the RFTP programme was mainly positive.
Conclusions: A multi-centre randomised controlled trial to evaluate an upper limb RFTP therapy programme provided
early after stroke is feasible and acceptable to patients and therapists, but there are issues which need to be addressed
when designing a Phase III study. A Phase III study will need to monitor and report not only recruitment and attrition
but also adherence to the intervention, usual post stroke rehabilitation received, and outcome assessor blinding.
Trial registration: International Standard Randomised Controlled Trials Number (ISRCTN) 58527251
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task practice
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Background
Loss of arm function affects 69 % of people who have a
stroke [1]. Only 12 % of stroke patients with initial upper
limb motor impairment regain full function [2]. Stroke
patients who are unable to use their arm may require
long term support from their families or social services.
Patients report that rehabilitation pays insufficient atten-
tion to arm recovery and they have identified optimising
arm function as a research priority [3]. It is currently un-
clear how to maximise arm recovery after stroke. A sys-
tematic review of upper limb therapy interventions
suggests that patients benefit most from exercise pro-
grammes in which functional tasks are directly practised,
rather than interventions which are impairment focused,
such as muscle strengthening [4].
Functional or task specific practice is underpinned by
the movement science approach to stroke rehabilitation
[5]. Repetitive functional task practice (RFTP) seeks to
enhance motor learning by undertaking practice of func-
tionally relevant tasks [6, 7]. Other key components
of RFTP include: intensity of practice; active cognitive
involvement; and feedback on performance [5]. A
Cochrane overview of systematic reviews found moder-
ate quality evidence that arm function following a stroke
can be improved by repetitive task training [8]. However,
included studies were small, often did not describe the
interventions in detail, and several had methodological
weaknesses [9–20]. The authors highlighted the need for
further high quality randomised controlled trials to
strengthen this evidence [8].
We aimed to establish the feasibility of a Phase III
multi-centre randomised controlled trial designed to
determine the clinical effectiveness of an upper limb
RFTP therapy programme for acute stroke patients.
The objectives of the pilot study were to report: the
recruitment rate; adherence to the upper limb RFTP
therapy programme; the usual post stroke rehabilitation
received by study participants; the attrition rate; data
quality; the success of outcome assessor blinding;
adverse events; and the views of study participants and
therapists about the intervention.
Methods
Study design
We conducted a multi-centre pilot randomised controlled
trial to inform the design of a Phase III study to evaluate
an upper limb RFTP therapy programme for acute stroke
patients. The Medical Research Council (MRC) guidance
was followed to develop and evaluate the intervention
[21]. A flowchart of the study design is shown in Fig. 1.
Study setting
Three National Health Service (NHS) stroke units in
North East England participated in the pilot study.
All provided in-patient acute stroke care and rehabili-
tation on a stroke unit and had community therapy
follow up services. They were typical of stroke services
which would be invited to participate in a multi-
centre study.
Participants
We aimed to recruit patients with a recent first-ever or
recurrent stroke resulting in new reduced upper limb
function. Inclusion criteria were: age ≥ 18 years; within
14 days of stroke onset; new reduced upper limb func-
tion but with retained ability to lift the affected hand any
distance off their lap; capable of undertaking the upper
limb RFTP therapy programme and adhering to the
study protocol; able to provide informed consent to par-
ticipate in the study; and home address within the com-
munity services catchment area of a participating study
site. Exclusion criteria were: unable to follow the upper
limb RFTP programme e.g. due to cognitive impairment
or receptive aphasia; other significant upper limb impair-
ment e.g. fixed contracture, frozen shoulder, severe arth-
ritis, and upper limb pain that inhibited participation in
the upper limb RFTP therapy programme; and a diagno-
sis likely to interfere with rehabilitation e.g. registered
blind, receiving palliative care. As this was a pragmatic
study, we did not use standardised scales to define any
inclusion or exclusion criteria. Inclusion and exclusion
criteria were based upon clinical opinion reflecting how
patients would be identified to receive the upper limb
RFTP programme in clinical practice. Screening was
undertaken by NHS research support staff at each site
who were Good Clinical Practice (GCP) certified and
trained by in study methods and procedures by the study
physiotherapist (LB).
Recruitment and consent
Potentially eligible patients were approached by NHS re-
search support staff who discussed the study with them
and provided a study information sheet. After allowing
sufficient time for this information to be considered,
written consent was obtained from patients who wished
to take part.
Baseline assessment
The following data were collected prior to randomisa-
tion by NHS research support staff: demographic data;
time from stroke; first-ever or recurrent stroke; stroke
type (infarct or haemorrhage); stroke subtype (total an-
terior circulation stroke (TACS), partial anterior circula-
tion stroke (PACS), lacunar stroke (LACS), posterior
circulation stroke (POCS)) [22]; stroke severity (National
Institutes of Health Stroke Scale (NIHSS)) [23]; pre-
stroke handicap (Oxford Handicap Scale (OHS)) [24];
hand dominance; arm function (Action Research Arm
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Test (ARAT)) [25], arm strength (Motricity Index) [26],
and grip strength (dynamometer).
Randomisation
Participants were randomised within 14 days of acute
stroke to receive the upper limb RFTP therapy programme
(in addition to usual post stroke rehabilitation) or usual
post stroke rehabilitation in a 1:1 allocation ratio. A central
independent web based randomisation service hosted by
Newcastle University Clinical Trials Unit was used. Partici-
pants were stratified according to study centre to ensure
that intervention and control group participants were
evenly distributed across study centres.
Development of the upper limb RFTP therapy programme
We reviewed the theoretical basis of RFTP and the
structure and content of the upper limb RFTP therapy
programmes which had been evaluated in previous re-
search [9–17]. The upper limb RFTP therapy programme
was then developed in collaboration with stroke physio-
therapists and occupational therapists. Feedback was
sought from clinicians, stroke patients and carers. The
therapy programme was then refined before being tested
in a clinical setting. Prior to undertaking the pilot rando-
mised controlled trial, the study physiotherapist who de-
veloped the programme (LB) delivered the upper limb
RFTP therapy programme to seven stroke patients in two
Target population: Patients who had a stroke within the previous 14 days resulting in reduced upper limb 
function. Participants were recruited from 3 stroke units in North East England.
Recruitment and consent: NIHR Stroke Research Network (SRN) staff identified potentially eligible patients 
and discussed the study with them. Study information sheets provided and written informed consent obtained.
Baseline assessment: Baseline assessments were performed within 14 days of stroke.
Central randomisation: Via web based service 
Control Group
Usual post stroke rehabilitation
All participants also received written advice 
and information about stroke rehabilitation
Intervention Group
A four week RFTP therapy programme for the 
upper limb was provided by NHS stroke 
therapists (in addition to usual post stroke 
rehabilitation)
All participants also received written advice 
and information about stroke rehabilitation
One month outcome assessment
Data collected by blinded assessors:
• Upper limb function (Action Research Arm Test (ARAT) [25]
• Grip strength (Dynamometer) 
• Arm strength (Motricity Index) [26]
• Extended Activities of Daily Living (Nottingham Extended Activities of 
Daily Living Index) [31]
• Adverse events
Three months outcome assessment
Data collected by blinded assessors: 
• Upper limb function (Action Research Arm Test (ARAT)) [25]
• Grip strength (Dynamometer)
• Arm strength (Motricity Index) [26]
• Extended Activities of Daily Living (Nottingham Extended Activities of 
Daily Living Index) [31]
• Adverse events 
At the end of the study, semi structured interviews with the study therapists who 
delivered the upper limb RFTP programme
Semi structured 
interviews with a 
sample of 
participants who 
received the upper 
limb RFTP 
programme
Fig. 1 Flowchart of the RAFTAS study design
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of the participating stroke units. As this was provided in
addition to usual post stroke rehabilitation, she worked
closely with participants’ local NHS therapists, ward teams
and community teams to ensure that care was coordi-
nated. Feedback from study participants and the experi-
ence gained by the study physiotherapist were used to
further refine the upper limb RFTP therapy programme.
The study physiotherapist developed and provided a face
to face training programme with regular updates and a
manual to enable local NHS therapists to deliver the
programme in the pilot study.
Intervention: the upper limb RFTP therapy programme
The upper limb RFTP therapy programme was a four
week programme of twice daily self-practised RFTP for
patients with new reduced upper limb function early
after stroke led by local NHS therapists (a physiotherap-
ist or occupational therapist). The programme com-
prised of functional tasks, embedded in routine everyday
activities completed on the ward or at home. This aimed
to make the programme highly relevant to participants,
promote ‘carry over’ into real life situations, and encour-
age self-practise.
With the support of local NHS therapists, participants
selected and practised functional tasks, termed recovery
activities, which involved goal-focused upper limb move-
ment sequences. Recovery activities related to categories
identified from the most popular participant-selected
goals in previous studies: washing, dressing and eating/
drinking [27, 28]. There was also an optional category
which enabled participants to select an activity which
was not listed under the other categories (e.g. using a
mobile phone). Optional tasks offered choice and aimed
to enhance participant motivation.
Participants were asked to practise each selected re-
covery activity independently for up to 20 times, twice
per day, for four weeks. For participants who were
unable to attempt a full task e.g. picking up a cup,
recovery activities were divided into part tasks e.g.
reaching towards the cup and practised in the same
way as full tasks. The duration and intensity of the
upper limb RFTP therapy programme were based
upon the interventions used in previous RCTs of RFTP
[9–17], the feasibility of delivering the intervention in
the NHS, and feedback from stroke patients and carers
in the development phase.
At the start of the programme, the local NHS therapist
performed a routine clinical assessment to determine
the patient’s upper limb impairment and to identify
other neurological deficits that may impact on upper
limb function (e.g. inattention or cognitive deficit). The
participant identified their two most important upper
limb rehabilitation priorities and these were used to set
two functional rehabilitation goals which were potentially
achievable within the four week programme. The therapist
and participant then selected two recovery activities from
lists created for each category. A wide range of recovery
activities was available in each category and they were or-
dered into three levels of ability which were generated by
considering sensorimotor demands (e.g. the amount of
upper limb movement and coordination required) and the
level of mental processing needed to complete the activity.
The local NHS therapist demonstrated the chosen re-
covery activities and ensured that the participant was
confident to practise them independently.
Intervention group participants were given an indivi-
dualised upper limb RFTP participant handbook. The
handbook included guidance about undertaking their
chosen recovery activities, along with sections to log
their twice daily practice and to provide feedback about
the upper limb RFTP therapy programme. The partici-
pant handbook also included a section with advice and
information concerning stroke recovery and care of their
affected upper limb. The local NHS therapist demon-
strated how to use the handbook and how to complete
the activity log sheets and feedback sections.
Participants were reviewed by the local NHS therapist
twice per week in hospital or at home. These sessions
consisted of a clinical re-assessment of the participant’s
affected upper limb impairment and review of progress
towards their chosen functional goals. The goals and/or
recovery activities were adjusted according to progress.
If the participant had achieved a goal, a new goal was set
and a new recovery activity was selected. If the partici-
pant found a goal or recovery activity too challenging,
alternatives were chosen. If a participant regained normal
upper limb function based upon the clinical assessment of
the therapist and achieved all of their upper limb rehabili-
tation goals before the end of the four week intervention
period, they were discharged from the programme. Other-
wise, participants received a final therapy review at the
end of the four week programme either in hospital or at
home. The final review included a discussion about the
participant’s future goals and advice about maintaining
upper limb function.
Control treatment
In the Phase III trial, as we wished to assess the effective-
ness of the intervention in addition to current upper limb
RFTP programme clinical practice, usual post stroke
rehabilitation was chosen as the control treatment. Parti-
cipants randomised to receive control treatment also
received a study handbook, prepared by the study team,
which contained advice and information about stroke, re-
habilitation and positioning of the arm and hand after
stroke. The duration and content of routine physiotherapy
and occupational therapy provided to intervention and
control group participants for 4 weeks post randomisation
Brkic et al. Pilot and Feasibility Studies  (2016) 2:50 Page 4 of 12
were recorded by local NHS therapists on a structured
proforma. We acknowledge that there is currently no
standard approach to upper limb rehabilitation post-stroke
as rehabilitation is tailored to the needs of each individual
and is dependent upon the availability of local resources
[29]. The National Clinical Guideline for Stroke recom-
mends a minimum 45 min of each appropriate therapy for
5 days per week [30].
Outcome assessments
Outcomes were assessed at one month (+/− 3 days) and
3 months (+/− 5 days) following randomisation. These
time points will be used in a Phase III study to look at the
treatment effect at the end of the intervention period and
to report the longer term effectiveness of the upper limb
RFTP therapy programme. The following data were col-
lected: arm function (Action Research Arm Test (ARAT))
[25]; grip strength (dynamometer); arm strength (Motricity
Index) [26]; extended activities of daily living (Nottingham
Extended Activities of Daily Living Index) [31].
Blinding
Outcome assessors were four therapists from stroke
units or community services. They were not involved in
the direct care of the participants and were intended to
be blinded to treatment allocation. As the upper limb
RFTP therapy programme involved regular practise and
assessment, it was not possible to blind stroke patients
or local NHS therapists who treated the patient to treat-
ment allocation. After each assessment, the assessor was
asked to record whether they had become unblinded.
We attempted to blind stroke unit staff to treatment al-
location by means of the study handbooks which were
given to both control and intervention groups and were
identical in external appearance.
Adverse events
The safety of the upper limb RFTP programme was eval-
uated by examining the occurrence of adverse events in
accordance with National Research Ethics Committee
(NRES) guidance for non Clinical Trial of an Investiga-
tional Medicinal Product (CTIMP) trials [32]. To collect
adverse event data, participants were asked at each out-
come assessment if they had any new medical problems.
Participants were also asked specifically about upper
limb pain and fatigue using visual analogue scales, and
muscle tone in the upper limb was assessed by the
Modified Ashworth Scale [33].
Feedback from intervention group participants and
therapists
Intervention group participants were asked to provide
feedback about the upper limb RFTP therapy programme
on their activity log sheets. They were also asked open
questions about their experiences and opinions about the
therapy programme at therapy reviews by local NHS ther-
apists. The study physiotherapist (LB) undertook semi-
structured 1:1 interviews with a convenience sample of
patients when they left/completed the therapy programme
and with the three main local NHS therapists who had
delivered the upper limb RFTP programme. These data
were coded and categorised into positive and negative
comments and themes.
Sample size and statistical analysis plan
As this was a pilot study a formal sample size calculation
was not performed.
We aimed to recruit 60 participants, based on 1–2
participants per month, from three study centres recruit-
ing for 1 year. This is the level of recruitment expected
per site for multi-centre stroke rehabilitation trials in the
UK [34]. Analysis of pilot studies should be mainly de-
scriptive [35, 36]. Numbers and percentages were used for
categorical variables. Mean and standard deviation (SD) or
median and interquartile range (IQR) were reported for
continuous variables. As data are available from larger
studies of upper limb interventions post stroke, which re-
cruited participants from a similar patient population and
used the same validated outcome measures, we did not
seek to use data from the pilot study to inform the sample
size calculation for a larger trial.
Results
The consolidated standards of reporting trials (CONSORT)
flow diagram is shown in Fig. 2.
Screening and recruitment
The planned recruitment period was 1 year but prepar-
ing study documents and seeking approvals took longer
than anticipated. The actual recruitment period was
03.06.13–28.02.14. Site A was open to recruitment for
30 weeks, site B 37 weeks, and site C 38 weeks. One
thousand and seventy nine patients were screened, and
55 eligible patients were identified. This was between 4
and 6 % of patients screened at each site.
The main recorded reason why patients were not eli-
gible was that they had no new reduced upper limb
function: 206/1010 (20 %). One hundred and eighty
one patients (18 %) were thought to be unable to com-
ply with the upper limb RFTP programme because of
speech or cognitive problems, and 147 (15 %) lived
outside the catchment area for community follow up
visits. The reason for exclusion was not recorded for
337/1010 (33 %).
Twenty four of the 55 (44 %) eligible patients took part
in the study. Site A recruited four participants, site B
nine participants and site C 11 participants. There was a
wide variation in the proportion of eligible patients
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recruited between sites. Site C recruited 11/11 (100 %)
eligible patients, site B recruited 9/23 (39 %) and site A
4/21 (19 %). Potentially eligible patients did not partici-
pate because 13 were already participating in another
study which did not allow co-enrolment (site A); a local
NHS therapist was not available to provide the RFTP
programme to seven patients (four site A and three site
B); NHS research support staff were not available to
consent six patients (site B); and a consultant advised
against approaching one patient (site B). Four patients
(site B) declined to take part in the study: one felt that
the upper limb RFTP therapy programme would be too
difficult; one felt that there was insufficient content;
and two did not give a reason. Two of the three study
sites were able to recruit the target of 1–2 participants
per month.
Characteristics of the study population
Table 1 shows the baseline characteristics of study par-
ticipants. Participants were randomised a median of 5
(IQR 2–11) days after stroke and had reduced upper
limb function with a median ARAT of 20 (IQR 3–35).
As could be anticipated in a small pilot study, interven-
tion and control groups were not well-matched at base-
line. Intervention group participants were older, had
less severe strokes with milder upper limb impairment
and function and were randomised earlier than control
group participants.
Intervention
Seven local NHS therapists (four physiotherapists and
three occupational therapists) were trained to deliver the
upper limb RFTP therapy programme. Of 13 intervention
Assessed for eligibility n=1,079
Excluded n=1,024
Did not meet inclusion criteria n=1,010
Unsure of eligibility status n=14 
Allocated to intervention n=13
Received allocated intervention n=12
Did not receive intervention due to 
administrative error n=1
Allocated to control n=11
Allocation
Assessment completed n=12
Assessment missed in error n=1
Assessment completed n=10
Withdrew n=1
Follow-Up (1 month)
Randomized n=24
Assessment completed n=10  
Unable to contact n=2
Assessment missed in error n=1
Assessment completed n=10
Follow-Up (3 month)
Eligible n=55Not recruited n=31
Patient declined n=4
Local study staff not available 
n=13 
Participating in another study 
n=13
Advised against approaching 
n=1
Fig. 2 RAFTAS CONSORT flow diagram
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group participants, four received the intended eight face-
to-face therapy sessions. Two were discharged early from
the programme as per protocol as they had achieved all of
their upper limb therapy goals and had regained full upper
limb function. One participant did not wish to undertake
recovery activities and was discharged from the therapy
programme. Two participants (site A) were reported to
have received the upper limb RFTP therapy programme
but documents were not returned to the coordinating
centre so it is unclear how many face to face sessions
they received. A further three participants did not
receive all eight sessions and the reasons for this are
Table 1 Baseline characteristics of participants
Intervention group Control group
n = 13 n = 11
Gender
Male n (%)
Female n (%)
8 (61.5 %)
5 (38.5 %)
9 (81.8 %)
2 (18.2 %)
Age
Median (IQR) years
Missing
71 [67–78]
2
65 [57–72]
1
Pre-stroke handicap (Oxford Handicap Scale [24])
0
1
2
3
Range 0–5: no symptoms – severe handicap
12 (92.3 %)
0
1 (7.7 %)
0
5 (45.5 %)
3 (27.3 %)
2 (18.2 %)
1 (9.1 %)
First ever stroke
Missing
8 (61.5 %)
0
8 (72.7 %)
0
Dominant hand affected by stroke
Missing
5 (38.5 %)
0
7 (63.6 %)
0
Time from stroke to randomisation
Median (IQR) days
Missing
6 [2.5–11.5]
0
4 [2–9]
0
Stroke type
Assumed infarct (no clinically relevant infarct on CT)
Clinically relevant infarct on CT/MRI
Intracerebral haemorrhage
Missing
0 (0 %)
11 (85 %)
0 (0 %)
2 (15 %)
3 (27 %)
5 (46 %)
1 (9 %)
2 (18 %)
Stroke sub-type (n %) [22]
Total anterior circulation syndrome (TACS)
Partial anterior circulation syndrome (PACS)
Lacunar stroke (LACS)
Posterior circulation stroke (POCS)
Missing
1 (8 %)
2 (15 %)
8 (62 %)
0 (0 %)
2 (15 %)
1 (9 %)
5 (46 %)
4 (36 %)
1 (9 %)
0 (0 %)
Stroke severity (National Institutes of Health Stroke Scale [23])
Median [IQR])
Missing
Range 0–42: no symptoms – severe impairment
3 [2–5]
1
6 [3–7]
0
Arm function (Action Research Arm Test [25])
Median (IQR)
Missing
Range 0–57: no movement – full function
32 [10–37]
0
8 [1–22]
0
Arm strength (Motricity Index) [26]
Median (IQR)
Missing
Range 0–100: no movement – normal strength
73 [48–77]
2
40 [29–52]
0
Grip strength (dynamometer)
Median (IQR) kg
Missing
12 [4–21]
2
7 [2–18]
0
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unclear (site A n = 1, site C n = 2). One patient did not
receive any of the upper limb RFTP therapy programme
as the local NHS therapist was not informed that the
patient was participating in the study (site B). The me-
dian number of therapy sessions delivered per patient
was 6 (IQR 3–8).
Sixty five upper limb rehabilitation goals were selected.
The goals related to: dressing n = 18 (28 %); washing n =
17 (26 %); eating/drinking n = 17 (26 %); 13 (20 %) were
in the optional category and related to activities such as
writing, handling money, kitchen activities and playing
cards. Sixty (92 %) goals were achieved during the study.
Participants returned activity log sheets for a median of
20 (IQR 2.5–24) days. Participants were asked to record
the number of repetitions for each recovery activity. The
intended maximum number of repetitions per day was
80 (20 repetitions of two activities, twice per day). The
median number undertaken daily was 80 (IQR 39–80,
range 0–150) for the 11 participants whose activity log
sheets were returned.
Usual post stroke rehabilitation
Information about usual post stroke rehabilitation was
available for 17/24 (71 %) participants. Data were avail-
able for a median of 8 (IQR 6–19.5) days per participant
for intervention group participants and 5 (IQR 3.5–11.5)
days for control participants. Unfortunately we did not
record when participants were discharged from usual
post stroke rehabilitation. The content of therapy ses-
sions was recorded for 238 sessions for intervention
group participants and 94 sessions for control group
participants. The intervention group/control partici-
pant sessions comprised: mobility 100 (42 %) vs 43
(46 %); upper limb RFTP 21 (9 %) vs 8 (9 %); other
upper limb rehabilitation 53 (22 %) vs 21 (22 %); activ-
ities of daily living 37 (16 %) vs 13 (14 %); and other 27
(11 %) vs 9 (10 %).
Attrition
Follow up at 1 month was 22/24 (92 %): one participant
withdrew from the study and one outcome assessment
was missed. Follow up at 3 months was 20/24 (83 %).
Three participants could not be contacted and one was
overlooked in error.
Outcome measures
Outcome measures at 1 and 3 months are shown in
Table 2.
The median ARAT score at one month was 55 (IQR
38–57) for the intervention group and 46 (IQR 29–57) for
the control group. At 3 months, the median ARAT score
for the intervention group was 57 (IQR 50–57) and con-
trol group 48 (35–57). The maximum score achievable on
the ARAT is 57. Levels of missing data were acceptable.
Blinding
Outcome assessors reported that they were unblinded to
participant group allocation for 11/22 (50 %) at 1 month
6/20 (30 %) at 3 months. The same assessor carried out
one and three month assessments for 20/21 (95 %) partici-
pants, so some assessors had forgotten that they felt un-
blinded at one month when they undertook the 3-month
assessment. Because of the large number of staff providing
care at each stroke unit, we did not try to measure the
success of group concealment among stroke unit staff.
Adverse events
Four adverse events were considered serious as they
resulted in hospitalisation: two falls, one episode of pos-
tural hypotension and one episode of gastritis. All were
considered unrelated to the upper limb RFTP therapy
programme. Seventeen adverse events were reported,
10 in the intervention group and seven in the control
group. All adverse events were considered unrelated to
the intervention.
Table 2 Clinical outcomes at 1 and 3 months
Intervention 1 month Control 1 month Intervention 3 months Control 3 months
n = 13 n = 11 n = 13 n = 11
Arm function (ARAT) [25]
Median (IQR)
Missing
55 [38–57]
1
46 [29–57]
2
57 [50–57]
3
48 [35–57]
1
Grip strength (dynamometer)
Median (IQR) kg
Missing
15 [8–20]
3
11 [5–26]
1
13 [5–21]
4
14 [4–28]
1
Arm strength (Motricity Index) [26]
Median (IQR)
Missing
91 [76–99]
1
79 [55–91]
1
88 [65–99]
3
88 [72–94]
1
Nottingham Extended Activities of Daily Living Scale [31]
Median (IQR)
Missing
36 [10–54]
5
34 [25–46]
2
43 [9–60]
3
52 [32–58]
2
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Participants were specifically asked about upper limb
pain, fatigue and assessed for increased muscle tone in
their affected arm. At 1 month 5/13 (38 %) participants
in the intervention group and 6/11 (55 %) participants in
the control group reported pain in the upper limb affected
by stroke. At 3 months, these corresponding data were
5/13 (38 %) in the intervention group and 5/11 (45 %)
in the control group. Nearly all participants reported
some degree of fatigue at 1 and 3 months. At 1 month
5/13 (38 %) participants in the intervention group and
5/11 (45 %) participants in the control group had
increased upper limb tone. At 3 months these corre-
sponding data were 3/13 (23 %) in the intervention
group and 5/11 (45 %) in the control group.
Feedback from intervention group participants and
therapists
During the 4-week upper limb RFTP therapy programme,
participants recorded 107 positive comments about
the programme on their therapy log sheets and 39
negative comments. Positive comments reported that
the programme was enjoyable, challenging and motiv-
ating. Negative comments predominantly related to
fatigue, although some participants found the programme
too challenging. At twice weekly therapy reviews, nine
participants gave positive comments to their local NHS
therapist about the upper limb RFTP therapy programme,
reporting that they felt they were benefiting from the
programme. Eight participants gave negative comments
about the programme which again predominantly related
to fatigue. One participant did not enjoy participating in
the upper limb RFTP therapy programme and another felt
that it aggravated a back problem. All of the seven partici-
pants who provided feedback at the end of the upper limb
RFTP therapy programme to their NHS therapist felt
that it was reasonable to start early after stroke. Six felt
that being reviewed twice per week by the local NHS
therapist was about right, and one felt that this was not
enough. Six found the participant handbook helpful. All
found goal setting useful. Three participants took part
in a 1:1 semi-structured interview with the study
physiotherapist upon completing the upper limb RFTP
therapy programme. No points were raised that had not
been identified previously.
The three therapists who had the most experience of
delivering the upper limb RFTP therapy programme par-
ticipated in semi-structured interviews at the end of the
study. They provided positive feedback about the upper
limb RFTP programme and gave some suggestions about
minor changes to study documents.
Discussion
We have demonstrated that a multi-centre randomised
controlled trial to determine the clinical effectiveness of
the upper limb RFTP therapy programme is feasible, but
there are a number of issues which need to be addressed
in the design and delivery of a Phase III study.
NHS site selection will be an important issue. One of
the strengths of the pilot study was that it was a multi-
centre study undertaken in sites which are typical of
sites which are likely to participate in a Phase III study.
Pilot studies are often undertaken in a single centre
where the chief investigator is based, with strong local
ownership and engagement of clinical and research
teams. This can lead to over-optimism about the feasi-
bility of a multi-centre study.
We have obtained valuable insight about issues which
are likely to be encountered in a Phase III study and
gained understanding about the type and amount of sup-
port which sites are likely to need from the study coord-
inating centre. Multi-centre stroke rehabilitation trials
are relatively rare, and two of the three sites had limited
experience of stroke rehabilitation research. In selecting
sites and throughout a Phase III study, we will need to
ensure that key individuals within the stroke unit and
community stroke teams are committed to the trial and
are able to deliver the study as per protocol. It may be
helpful to have several linked sites within a region which
are supported by a local study coordinator.
The recruitment target of 1–2 participants per month
was met by two of the three study sites. It would not
have been possible for sites to have more than two inter-
vention participants at any one time because of the add-
itional work load for local NHS therapists. We felt that
it was important that the upper limb RFTP therapy
programme was delivered by the local NHS therapists
rather than research therapists so that the intervention
was evaluated as it would be delivered in clinical prac-
tice. Funding for the upper limb RFTP programme was
a NHS excess treatment cost [37]. The excess treatment
cost was the cost of the upper limb RFTP programme
over and above usual post stroke rehabilitation. Excess
treatment costs are not research costs funded by a grant,
but are costs funded by the normal NHS commissioning
process for stroke rehabilitation services. Our experience
of leading multi-centre stroke rehabilitation trials over
the last 10 years is that there is wide variation between
NHS organisations in their approach to NHS excess
treatment costs. Some NHS organisations provide add-
itional funding to individual therapists or rehabilitation
services to deliver study treatments, whilst others agree
for study treatments to be undertaken within the current
service budget. In this pilot study, the programme was
delivered by local NHS therapists in addition to their
usual work load and therapists did not always have dedi-
cated time to provide the intervention and to complete
study documents. In selecting sites for a Phase III study, we
will need to consider their approach to excess treatment
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costs and the views of local therapists about delivering the
upper limb RFTP programme within the local excess treat-
ment costs policy. The approach of a NHS organisation to
excess treatment costs may impact upon whether or not a
site agrees to participate in the study, the delivery of the
intervention, and data quality about the intervention and
usual post stroke care.
Although the recruitment target was met in two of the
three sites, a large proportion of eligible patients were
not enrolled (56 %) and there was a wide variation
between sites. A number of eligible patients were not
approached at site A as they were participating in stud-
ies which did not allow co-enrolment. These were hyper-
acute and acute drug studies. Provided that there are no
potential interactions between interventions, and as-
sessments are not too burdensome, patients should be
offered the opportunity to participate in a second study.
In selecting sites for a Phase III study, we will need to
determine the compatibility of our study with the site’s
portfolio of research studies and discuss co-enrolment
with the chief investigators of ongoing studies.
Another reason for non-enrolment of potentially eli-
gible patients relates to the lack of availability of NHS
research support staff to recruit participants and local
NHS therapists to deliver the upper limb RFTP therapy
programme. Two sites had no prospective cover for ab-
sence. Although there was more than one NHS therapist
trained to deliver the upper limb RFTP therapy programme
at each site, when a member of the therapy team was away,
the time available for research activities was reduced, so pa-
tients could not be randomised. There was no ring fenced
resource to provide study treatments, reflecting the reality
of undertaking multi-centre rehabilitation studies within
the NHS. The Phase III study design will need to allow for
the impact holidays, sick leave, change of staff etc. upon
recruitment and delivery of the intervention.
Our eligibility criteria were pragmatic and based upon
clinical judgement, as would be used to decide whether
or not to provide the treatment in clinical practice. We
may need to include arm function measured by the
ARAT as an eligibility criterion for a Phase III study
[25]. This measure of arm function is likely to be our
primary outcome as it is well-validated and is widely
used in studies evaluating upper limb rehabilitation post
stroke. The maximum ARAT score is 57 and the minimum
clinically important difference is 6 points [38]. Because of a
ceiling effect, we will need to consider excluding patients
who score 52 or above at baseline so that we will be able to
detect this change at 1 and 3 months (three participants
in the pilot study scored 52 or more at the baseline as-
sessment). It would have been helpful to have assessed
the inter-rater reliability of the ARAT and other key
scales within the pilot study. This work will need to be
undertaken during a Phase III study.
Participants were willing to take part in the study
within 14 days of acute stroke and felt that this was a
reasonable time to be approached. Intervention and con-
trol groups were not well matched at baseline. This is
likely to be due to a small sample size and should not be
an issue in a larger study. As it is important that groups
are balanced at baseline in terms of severity of upper
limb function, participants will be stratified by this par-
ameter at randomisation in a Phase III study.
The intervention has been carefully developed with
patient and carer involvement at all stages. Participants
were able to practise recovery activities themselves as
per protocol with twice weekly review by a therapist
both in hospital and at home.
The study manual and supporting documents can be
used in a Phase III study and adhere to TIDieR (tem-
plate for intervention description and replication) [39].
There is wide variation in clinical practice regarding
the amount and content of upper limb rehabilitation
provided, so in a future study, there is a need to accur-
ately record the amount and content of the usual post
stroke rehabilitation received by participants in both
randomisation groups. As there were a number of non-
returned or poorly completed therapy forms in the pilot
study, methods of minimising this need to be included
in a Phase III study. More information was available
about the usual post stroke rehabilitation received by
intervention group participants than those in the control
group, which could be a source of bias about the
amount and content of therapy received. The forms used
to record the amount and content of the intervention
and usual post stroke rehabilitation will be reviewed by
the study team and NHS therapists to see if they can be
simplified and/or reduced. We need to develop a robust
system of ensuring their return to the study coordinating
centre, with regular checks for data completeness and
data quality. Alternatively, an electronic system could be
developed to collect data with reminders and prompts
but additional resource would likely be needed to sup-
port local data entry. We also need to stress in our train-
ing programme for local NHS therapists the importance
of obtaining high-quality data.
The timing and content of outcome assessments will re-
main unchanged in a Phase III study. The attrition rate
observed in the pilot study and completeness of key out-
come measures are acceptable for a stroke rehabilitation
study but could be improved. In a Phase III trial, we will
consider using electronic prompts and reminder letters
for outcome assessors to try to prevent assessments being
missed. We will review methods to try to prevent partici-
pants being lost to follow-up by seeking information about
discharge destination when a participant leaves hospital.
Lack of blinding can result in numerous sources of
bias. Particular risks for stroke rehabilitation trials are
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resentful demoralisation of participants randomised to the
control group [40] and competitive therapy bias, where
therapy staff may feel that patients in the control group
are disadvantaged and subsequently provide them with in-
creased rehabilitation [41]. We did consider developing an
attention control treatment, but this would have added to
the complexity and cost of the trial. We were disappointed
that a large number of assessments was unblinded at the
1- and 3-month outcome assessments. Unfortunately, we
did not collect data about when and how outcome asses-
sors became unblinded and in retrospect this would have
been useful. All outcome assessors worked within the
stroke unit and community stroke services at the site
where they undertook assessments. For a Phase III study,
we will consider employing outcome assessors who work
out with the stroke service.
The upper limb RFTP therapy programme was accept-
able to patients early after stroke and local NHS thera-
pists and the majority of goals were achieved. A number
of patients in both intervention and control groups ex-
perienced fatigue. This is likely to be stroke related ra-
ther than specific to the intervention as there is a high
prevalence of fatigue following stroke [42]. Fatigue needs
to be taken into account when considering rehabilitation
goals. During a Phase III study, an Independent Data
Monitoring and Ethics Committee (IDMEC) will moni-
tor differences between intervention and control groups
in levels of fatigue. No concerns about the safety of the
upper limb RFTP programme were identified in the pilot
study, and the safety reporting system can be used in a
multi-centre study.
Conclusions
A multi-centre randomised controlled trial to evaluate an
upper limb RFTP therapy programme provided early after
stroke is feasible and acceptable to patients and therapists,
but there are issues which need to be addressed when de-
signing a Phase III study. A Phase III study will need to
monitor and report not only recruitment and attrition,
but also adherence to the intervention, usual post stroke
rehabilitation received and outcome assessor blinding.
Because of issues found in the pilot study, a Phase III
multi-centre study will require an internal pilot study
with stop/go rules based upon recruitment rate, adherence
to the intervention, attrition and completeness of outcome
assessments. The internal pilot study will determine if the
actions taken to address the issues raised in the current
pilot study have been successful.
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